Overview

Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer

Status:
Completed
Trial end date:
2018-12-14
Target enrollment:
Participant gender:
Summary
To investigate the safety of Prasaprohyai 95% ethanolic extract at doses of 100 mg and 200 mg for for 6 weeks. (Clinical Trial phase I)
Phase:
Phase 1
Details
Lead Sponsor:
Thammasat University
Collaborator:
Thai Traditional Medical Knowledge Fund